Glycosylated-drug Delivery as Targeted Therapy for Hepatocellular Carcinoma: Are We There Yet?

Curr Pharm Des. 2023;29(31):2439-2441. doi: 10.2174/0113816128269619231018074301.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Carcinoma, Hepatocellular* / drug therapy
  • Drug Delivery Systems
  • Humans
  • Liver Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents